Expert Interviews

Watch video interviews with thoracic oncology experts to learn about the latest developments in lung cancer treatment and research.

NSCLC Roundtable
ASCO 2025: Dr. Osarogiagbon Highlights How Lung Cancer Screening Saves Lives
Dr. Osarogiagbon shared insights on findings from the incidental lung nodule program and lung cancer screening program.
Advertisement
Jessica Bauman, MDASCO 2025 | June 25, 2025
Jessica Bauman, MD, discusses a new analysis of the REACH PC study that she presented at ASCO 2025.
View More
Jorge Nieva, MDASCO 2025 | June 30, 2025
Jorge Nieva, MD, discusses a recent study that evaluated the impact of circadian rhythms on the efficacy of immunotherapy.
Stephen V. Liu, MDNon-Small Cell Lung Cancer | June 24, 2025
Stephen Liu, MD, shares his insights on the recent approval, the data behind it, and what the future may hold.
Jennifer W. Carlisle, MDASCO 2025 | June 24, 2025
Jennifer Carlisle, MD, shares her institution’s experience with outpatient administration of the bispecific T-cell ...
Coral Olazagasti, MDASCO 2025 | June 24, 2025
Coral Olazagasti, MD, reflects on ASCO 2025 updates and the importance of bringing this news back to patients in the clinic.
Raffaele Califano, MDEGFR+ NSCLC | June 24, 2025
Dr. Califano discusses what the study showed about baseline mechanisms of resistance to osimertinib and associated outcomes.
Molly Li, MBBSASCO 2025 | June 24, 2025
The study participants include those who have had at least one first-degree relative diagnosed with lung cancer.
Sophie Poznanski, PhDASCO 2025 | June 24, 2025
Sophie Poznanski, PhD, shares insights from her ASCO 2025 presentation on the multifunctional antibody modality.
Matthew Smeltzer, PhDASCO 2025 | June 20, 2025
The study compared results from North America with global results by high-income and low- or middle-income countries.
Cheryl Czerlanis, MDASCO 2025 | June 19, 2025
Cheryl Czerlanis, MD, shares insights from the session on lung cancer screening that she chaired at ASCO 2025.
Shriya GargASCO 2025 | June 3, 2025
Palliative care researchers discuss differences in lung cancer treatment disparities across Hispanic patient subgroups.
Helena Yu, MDASCO 2025 | June 6, 2025
Helena Yu, MD, discusses research updates from REZILIENT1 that were presented at ASCO 2025.
Jennifer W. Carlisle, MDASCO 2025 | June 19, 2025
Jennifer Carlisle, MD, discusses amivantamab, and the multidimensional impact of toxicity management at ASCO 2025.
Coral Olazagasti, MDConference Coverage | June 1, 2025
Coral Olazagasti, MD, shares why the ASCO Annual Meeting is a critical time to bring the field together.
Raj Bhardwaj, MDNon-Small Cell Lung Cancer | May 29, 2025
Dr. Sanjay Juneja and Dr. Eric Singhi join a special episode of DDx for a candid conversation on a real patient case.
Eric Singhi, MDConference Coverage | June 1, 2025
Dr. Singhi unpacks the thoracic oncology data and highlights coming up at this year's ASCO Annual Meeting.
Stephen V. Liu, MDConference Coverage | June 1, 2025
Stephen V. Liu, MD, shares what he sees as the key upcoming highlights in thoracic oncology at the ASCO Annual Meeting.
Eric Singhi, MDNon-Small Cell Lung Cancer | May 23, 2025
Eric Singhi, MD, discusses the recent FDA approval and explains the associated new biomarker testing considerations.
Mara B. Antonoff, MDLung Cancer | May 21, 2025
Mara Antonoff, MD, explains the nuances of determining if a patient with oligometastatic disease is a candidate for surgery.
Cecilia BrownLung Cancer | May 15, 2025
Ravi Rajaram, MD, MSc, discusses Medicaid expansion, timely access to care, regionalization effects, and remaining questions.
Michael R. Gieske, MDLung Cancer | May 9, 2025
Michael R. Gieske, MD, discusses why Lung Cancer Action Week is a key time to promote screening and shares recent milestones.
Stephen V. Liu, MDLung Cancer | May 9, 2025
Dr. Liu discusses his experience as co-chair of the Texas Lung Cancer Conference and shares key highlights.
Alexander Spira, MD, PhDELCC 2025 | May 8, 2025
Dr. Spira shares key data from cohort C of CHRYSALIS-2 that was presented at the European Lung Cancer Congress 2025.
Mara B. Antonoff, MDLung Cancer | May 6, 2025
Mara Antonoff, MD, discusses key advances and addresses common misconceptions about operating in oligometastatic disease.
Jared Weiss, MDELCC 2025 | May 2, 2025
Dr. Weiss noted the results in both feasibility and safety, particularly via injection, which had limited complications.
Mara B. Antonoff, MDLung Cancer | April 30, 2025
Dr. Mara Antonoff discusses why it's critical to offer information and updates on surgery for oligometastatic lung cancer.
Stephen V. Liu, MDEGFR+ NSCLC | April 24, 2025
Dr. Liu discusses key data and updates in EGFR-positive NSCLC from the European Lung Cancer Congress.
Nicolas Girard, MD, PhDELCC 2025 | April 16, 2025
Nicolas Girard, MD, PhD, discusses data on subcutaneous amivantamab in patients with advanced NSCLC.
Martin Reck, MD, PhDELCC 2025 | April 12, 2025
The session covered everything from new actionable immune checkpoints to vaccines, cellular therapies, and bispecifics.
Martin Reck, MD, PhDELCC 2025 | April 9, 2025
Martin Reck, MD, PhD, reflects on key updates in stage III NSCLC from the European Lung Cancer Congress 2025.
Advertisement
Advertisement
Latest News

July 3, 2025